Ryght, Inc.

Ryght is the AI-native site intelligence platform to power better site selection and feasibility for clinical trial teams. Sponsors and CROs use Ryght to find, evaluate, and engage the right investigator sites in a fraction of the time and cost of traditional approaches — compressing timelines from months to weeks on the most critical path in trial startup.

Our AI-native platform is powered by AI Site Twins covering over 100k research sites worldwide and proprietary scoring that ranks country, site, trial, and investigator fit against any protocol. Ryght supports the full feasibility workflow — from self-service site selection, to fully delivered site identification and pre-feasibility outreach, to API-validated investigator contact data with bounce rates a fraction of industry norms, to direct data integration for sponsors augmenting their existing stacks. Learn more at ryght.ai.

website